-
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
Monday, December 27, 2021 - 3:16pm | 1200Image provided by Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Annovis Bio Inc. (NYSE: ANVS) is a clinical-stage pharmaceutical company focused on developing drugs for...
-
The Past Week's Notable Insider Buys Included Digitalbridge, Life Time, A SPAC And More
Saturday, October 16, 2021 - 1:15pm | 671Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain. With the new earnings season underway, this week's most notable insider purchases were made by 10% owners. A SPAC about to go public and a recent initial public offering prompted...
-
Annovis Bio Presents Novel Treatment For Alzheimer's And Parkinson's Diseases
Thursday, March 18, 2021 - 11:21am | 887The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Seeing someone we love going through a degenerative disease is painful and takes a tremendous toll on the people around them as they...